A computational model identifies metabolites associated with Parkinson’s disease

Researchers identify significant metabolites involved in the development and progression of Parkinson’s disease.

From drug shortages to high prices, U.S. system’s shortcomings have deep roots

American medicine is a tragic paradox. An example: Cancer patients are likely dying as a result of drug shortages that occurred partly because generic chemotherapies

August 15, 2023

Cybin Scores Breakthrough Therapy Designation for Deuterated Psilocybin Analog in MDD, Shares 4-Month Data – Psychedelic Alpha

Today, psychedelic drug developer Cybin announced that it has received breakthrough therapy designation for CYB003, its deuterated psilocybin analog candidate under development for major depressive

March 13, 2024

The biotech news you missed from the weekend

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello from ASH! Writing

December 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.